通心络与低分子肝素联合治疗急性脑梗死临床分析  

Clinical effect of tongxinluo capsule and low molecular weight heparin calcium on acute ischemic stroke

作　　者：杨春海[1] 张会军[1] 代全德[1] 

机构地区：[1]河南商丘市第一人民医院神经内科,商丘476100

出　　处：《中国实用神经疾病杂志》2009年第24期27-28,共2页Chinese Journal of Practical Nervous Diseases

摘　　要：目的探讨通心络与低分子肝素联合治疗急性脑梗死的疗效。方法将256例急性脑梗死病人随机分为2组,对照组常规治疗;治疗组在常规治疗的基础上加用通心络胶囊4粒/次,tid,连用4周为一个疗程。低分子肝素钙5000U,皮下注射,q12h,连用7d。结果治疗组总有效率87.5%,优于对照组的74.2%,2组比较差异有统计学意义(P<0.05)。结论通心络与低分子肝素合用治疗急性脑梗死有显著疗效。Objective To investigate the clinic al effect of tongxinluo capsule and low molecular weight heparin calcium on acute ischemic stroke. Methods Two hundred and fifty-six patients with acute ischemic stroke were randomly divided into two groups： routine group and tongxinluo capsule group. The patients in routine group were offered treatment with routine therapy; the patients in tongxinluo capsule group were offered with routine therapy and tongxinluo capsule and low molecular weight heparin calcium. Tongxinluo capsule was taken for four weeks （three capsules, rid） and low molecular weight heparin calcium 5000U was subcutaneous injection for seven days （q12h）. Results The total effectiveness of tongxinluo capsule group was 87.5%; the total effectiveness of control group was 74.2%. The statistic results had remarkable difference （P〈0.05）. Conclusion It is effective and safe that the patients with acute iscbemic stroke treated with tongxinluo capsule and low moiecular weight heparin calcium.

关 键 词：急性脑梗死 通心络 低分子肝素 

分 类 号：R743.33[医药卫生—神经病学与精神病学]